TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French...
TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
TNF-alpha inhibitors have revolutionized the therapeutic care in chronic inflammatory diseases. Several biosimilar products were commercialized at their patent expiry, substantially decreasing the cost of treatment. This longitudinal descriptive study aimed at assessing infliximab, etanercept and adalimumab biosimilar penetration rates using data o...
Alternative Titles
Full title
TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_597d7c77fc044ea9847b7f7c49cc5be2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_597d7c77fc044ea9847b7f7c49cc5be2
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-022-24050-7
